Malaria downmodulates mRNA expression and catalytic activities of CYP1A2, 2E1 and 3A11 in the mouse liver. European journal of pharmacology [Eur J Pharmacol] Journal article | | Title | Malaria downmodulates mRNA expression and catalytic activities of CYP1A2, 2E1 and 3A11 in the mouse liver. | | Author(s) | Carvalho RS, Friedrich K, De-Oliveira AC, Suarez-Kurtz G, Paumgartten FJ | | Institution | Institute of Medical Biochemistry, Federal University of Rio de Janeiro, RJ, Brazil; Division of Pharmacology, Research Section, National Cancer Institute, Rio de Janeiro, RJ, Brazil. | | Source | Eur J Pharmacol 2009 Jun 3. | | Abstract | It has been reported that malaria reduces cytochrome-P450 (CYP) content and monooxygenase activities in the mammalian host liver. The mechanism by which malaria modulates CYP activities, however, remains unclear. In this study we found that activities of ethoxy- and benzyloxy-resorufin-O-dealkylases, p-nitrophenol-hydroxylase and erythromycin-N-demethylase (mediated by CYP1A, 2B, 2E1 and 3A, respectively) were depressed, while uridine-glucuronosyl-transferase (a phase 2 enzyme) was unaltered in liver microsomes of Plasmodium berghei-infected (parasitemia >20%) male Swiss Webster mice. Prolongation of midazolam sleeping time and a slower clearance of chlorzoxazone were also noted in infected mice. Reductions of hepatic levels of CYP1A2, 2E1 and 3A11 mRNAs indicated that malaria downregulated these CYP-mediated activities at a pre-translational level. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 19501084 |
|
|
| |
Advertise on this site.
| | |
|
